Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer.
Wang BY, Zhang J, Wang JL, Sun S, Wang ZH, Wang LP, Zhang QL, Lv FF, Cao EY, Shao ZM, Fais S, Hu XC.
Wang BY, et al. Among authors: wang zh, wang jl, wang lp.
J Exp Clin Cancer Res. 2015 Aug 22;34(1):85. doi: 10.1186/s13046-015-0194-x.
J Exp Clin Cancer Res. 2015.
PMID: 26297142
Free PMC article.
Clinical Trial.